Dr Ruth Barrett
After completing her undergraduate degree in Biological Sciences at the University of Oxford, Ruth completed her PhD at Cambridge in Developmental Genetics in 2002. She then joined the Cambridge spin-out Daniolabs Ltd, becoming a Senior Research Associate and staying with the company from its inception in 2002 to its sale to Summit Plc in 2007. Ruth then spent two years as a consultant at PharmaVentures, where she focussed on commercial projects such as licensing, valuations (including ENPVs and benchmarking), deal analysis, fund raising assistance, due diligence and business plan assessment, primary/secondary research and competitive landscape analysis. As part of PharmaVentures’ Transactions team, Ruth was intimately involved with two successful, multi-million dollar divestments of API manufacturing businesses, from the Dow Chemical Company and Helsinn Healthcare. Ruth joined Oxford University Innovation as a Technology Transfer Manager in August 2009.